These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19033827)

  • 21. Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.
    Ross MI; Wu E; Wilkins JT; Gupta D; Shen S; Aulwes D; Montero K; Holly TA
    J Nucl Cardiol; 2013 Apr; 20(2):197-204. PubMed ID: 23404232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
    Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA
    J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging.
    Doukky R; Nigatu A; Khan R; Anokwute C; Fughhi I; Ayoub A; Iskander F; Iskander M; Kola S; Sahyouni M; Karavolos K; Hota BN; Gomez J
    J Nucl Cardiol; 2020 Oct; 27(5):1521-1532. PubMed ID: 30132187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve.
    Arumugham P; Figueredo VM; Patel PB; Morris DL
    EuroIntervention; 2013 Feb; 8(10):1166-71. PubMed ID: 23164748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogs.
    Zhao G; Zhang S; Shryock JC; Xu X; Ochoa M; Hintze TH; Belardinelli L
    J Nucl Cardiol; 2012 Feb; 19(1):109-17. PubMed ID: 22135160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Asystole after regadenoson administration to perform a myocardial perfusion imaging test].
    Briegas Morera D; Martín Clavo S; Estepa Alonso MJ; Rangel Mayoral JF
    Farm Hosp; 2017 Jul; 41(4):563-564. PubMed ID: 28683710
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
    Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regadenoson in the detection of coronary artery disease.
    Buhr C; Gössl M; Erbel R; Eggebrecht H
    Vasc Health Risk Manag; 2008; 4(2):337-40. PubMed ID: 18561509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Ballany W; Mansour K; Morales Demori R; Al-Amoodi M; Doukky R
    J Nucl Cardiol; 2014 Jun; 21(3):496-502. PubMed ID: 24519563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study.
    Townsend R; Desai A; Rammelsberg D; Kowalski D; Simmons N; Kitt TM
    J Nucl Cardiol; 2017 Feb; 24(1):57-65. PubMed ID: 26607361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of regadenoson for vasodilation in cardiac MRI stress tests.
    Bastarrika G; Ezponda A; Baizan AG; Calvo M; Pueyo JC; Gavira JJ; Caballeros M
    Radiologia (Engl Ed); 2020; 62(3):213-221. PubMed ID: 31862182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist.
    Le DE; Bragadeesh T; Zhao Y; Wang YG; Zha D; Kaul S
    Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):298-308. PubMed ID: 22067143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of regadenoson in patients with severe chronic obstructive pulmonary disease.
    Salgado-Garcia C; Jimenez-Heffernan A; Ramos-Font C; Lopez-Martin J; Sanchez-de-Mora E; Aroui T; Lopez-Aguilar R; Rivera-de-Los-Santos F; Ruiz-Frutos C
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):283-6. PubMed ID: 27160774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of regadenoson positron emission tomography stress testing in orthotopic heart transplant patients.
    Lazarus JJ; Saleh A; Ghannam M; Aaronson K; Colvin M; Pagani F; Koelling T; Corbett JR; Weinberg RL; Murthy VL; Konerman MC
    J Nucl Cardiol; 2020 Jun; 27(3):943-948. PubMed ID: 30483958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
    Cerqueira MD; Nguyen P; Staehr P; Underwood SR; Iskandrian AE;
    JACC Cardiovasc Imaging; 2008 May; 1(3):307-16. PubMed ID: 19356442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asystole following regadenoson infusion in stable outpatients.
    Rosenblatt J; Mooney D; Dunn T; Cohen M
    J Nucl Cardiol; 2014 Oct; 21(5):862-8. PubMed ID: 24879452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regadenoson.
    Bengalorkar GM; Bhuvana K; Sarala N; Kumar TN
    J Postgrad Med; 2012; 58(2):140-6. PubMed ID: 22718059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Amer KA; Hurren JR; Edwin SB; Cohen G
    Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.